Biotechnology company developing orally available therapeutics derived from molecules produced by symbiotic organisms, particularly intestinal worms
Biotechnology company developing orally available therapeutics derived from molecules produced by symbiotic organisms, particularly intestinal worms. Its drug candidates aim to modulate inflammation, metabolism, and tissue regeneration to address immune-related and chronic diseases, including eosinophilic esophagitis and autoimmune conditions.